🔎 MiLabs Research Spotlight
New Nature Immunology study shows lung-specific SARS-CoV-2 T cells help clear the virus & form resident memory for lasting protection! MiXCR powered immune profiling in this breakthrough.
📖 Read more: t.co/umQZUqUH69
#COVID19 #MiXCR #MiLabsResearchSpotlight
🔎 MiLabs Research Spotlight:
Proud to share a Nature Medicine study where part of our team contributed! 🎉
Selective depletion of TRBV9+ T cells led to 4+ years of remission in ankylosing spondylitis—without broad immunosuppression! 🚀
www.linkedin.com/posts/milabo...
#Immunotherapy #MiXCR
🔎 MiLabs Research Spotlight: A recent Nature study by Foy et al. showcases a CRISPR–Cas9 non-viral approach for personalized TCR replacement in cancer therapy! 🎯
MiXCR powered immune repertoire profiling in this breakthrough! 👏
#Immunotherapy #TCR #CRISPR #MiXCR
www.linkedin.com/posts/milabo...
🔎 MiLabs Research Spotlight
A recent study using MiXCR identified 685 full-length monoclonal antibody light chain sequences from untargeted RNA-seq in multiple myeloma patients—the largest dataset to date!
📖 Read more: linkedin.com/posts/milabo...
#MiLabs #MiXCR #MultipleMyeloma #AntibodySequencing
📢 New MiLabs Research Spotlight!
SLAMF7 and the Aging Immune System
🧬 SLAMF7+ T cells help track T cell differentiation & immune aging
🦠 Chronic infections accelerate T-cell exhaustion
www.linkedin.com/posts/milabo...
#Immunology #TCells #Aging #MiXCR #ImmuneRepertoire #Bioinformatics #SLAMF7
Festival of Genomics and Biodata London is happening this week!
Stop by booth number 72 to meet out team and see Platforma in action.
Here is a link to learn more about the event: hubs.la/Q02Tqk7j0
We can’t wait to connect with you!
#genomics #FOG2025 #Platforma #MiXCR
🌳 Introducing Somatic Hypermutation Trees Block in Platforma! 🌳
We are excited to launch Platforma’s new SHM Tree block - a powerful application in our Antibody Discovery Toolkit!
Check this demo to learn more:
www.loom.com/share/a88754...
#AntibodyDiscovery #Immunology #NGS #Platforma #MiXCR